Evaluation of the effects of anakinra treatment on clinic and laboratory results in patients with COVID-19
Description
CONCLUSION: We found that earlier and appropriate use of anakinra therapy in COVID-19 patients with the signs of macrophage activation syndrome reduces the need for oxygen support in patients and contributes to improvement in laboratory results and
